Joylux key facts
as of Oct 2026- Operator of an online wellness platform intended to provide vaginal health devices and menopausal products.
- Joylux is valued at approximately $28.7M as of Oct 2026, set at its later-stage round, Dec 2024; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $22.4M across 4 recorded rounds; the latest was Seed Round ($4.5M) in Sep 2024.
- Notable investors include Impact Assets, Springboard Enterprises, Keiretsu Forum, New York Angels, Reform Ventures — 40 tracked in total.
- Joylux has filed 7 Form Ds with the SEC since 2015, most recently Dec 2024 ($4.5M sold to 79 investors).
- Status: Privately Held (backing).
Valued at $28.7M at its later-stage round, Dec 2024. Nothing has traded since.
- ·The complete investor list: 40 names
- ·Watch Joylux: the Monday email on marks, rounds and moves
Joylux funding rounds
4 roundsWho backs Joylux
40+Joylux valuation
Joylux was valued at $28.7 million at its later-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Joylux raised?
Joylux has raised $22.4 million across 4 recorded rounds since 2015. The largest was a $6.3 million early-stage round in Dec 2017; the most recent was a $4.5 million seed round in Sep 2024.
Joylux has filed 7 Form Ds with the SEC since 2015, most recently in Dec 2024 ($4.5 million sold to 79 investors).
Joylux investors
40 investors are on record for Joylux, including Impact Assets, Springboard Enterprises, Keiretsu Forum and New York Angels. By type, the record holds 3 venture capital firms and 2 family offices. The seed round in Sep 2024 drew 79 investors.
Comparable companies
Comparable personal products names by valuation on PrivateMarketView: Because Market ($99 million), Luwi ($25 million) and Moxie Beauty ($8.9 million).
About Joylux
Operator of an online wellness platform intended to provide vaginal health devices and menopausal products. The company's products use photobiomodulation technology to help alleviate genitourinary syndrome of menopause, while collecting robust health data, enabling women customers to predict what symptoms they are likely to face as they go through the change to drive better health outcomes for them.
- Industry
- Personal Products
- Sector
- Consumer Products and Services (B2C)
- HQ
- Seattle, WA, United States
- Founded
- 2013
- Employees
- 20
- Website
- joylux.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.